Old Web
English
Sign In
Acemap
>
authorDetail
>
Lisa Diana MacDonald
Lisa Diana MacDonald
Halifax
DPX-Survivac
Pathology
Medicine
Cyclophosphamide
low dose cyclophosphamide
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DPX-Survivac and intermittent low-dose cyclophosphamide (CPA) with or without epacadostat (E) in the treatment of subjects with advanced recurrent epithelial ovarian cancer (DeCidE1 trial): T cell responses and tumor infiltration correlate with tumor regression.
2019
Journal of Clinical Oncology
Janos L. Tanyi
Oliver Dorigo
Amit M. Oza
James Strauss
Tanja Pejovic
Sharad A. Ghamande
Prafull Ghatage
Jeannine Villella
Stephan Fiset
Lisa Diana MacDonald
Olga Hrytsenko
Marianne M. Stanford
Robert C. Newton
Lance Leopold
Gabriela Nicola Rosu
Show All
Source
Cite
Save
Citations (0)
Early response assessment through multiparametric MRI based endpoints in a phase II multicenter study evaluating the efficacy of DPX-Survivac, intermittent low dose cyclophosphamide (CPA) and pembrolizumab combination study in subjects with solid tumors.
2019
Journal of Clinical Oncology
Diana Roettger
Faiq Shaikh
Sotirios Bisdas
Lisa Diana MacDonald
Stephan Fiset
Gabriela Nicola Rosu
Show All
Source
Cite
Save
Citations (0)
1